Newswire to provide unlimited press release distribution in support of Viratech's open source platform

Photo of author

STOCKTON, CALIFORNIA/November 29, 2012 /Newswire/ — Viratech Corp. (OTC: VIRA) and Newswire, announced today a new collaborative agreement between Viratech Corp and Newswire to distribute news of Viratech’s Micro Social Network operators.  Viratech has developed a landmark open source biotech research social network platform. Using this platform, individual and small business members of Viratech’s social network can protect the intellectual property for their biotech technology, then use Viratech’s Micro Social Network as a utility to promote and crowdfund the research and development to produce the new technology.

Newswire views Viratech’s business model (Protect, Promote, Produce) as a unique and unparalleled path to opening up the speed of new technology advancement. Under “Protect”, the business model shows how to protect intellectual property while the patent is pending by the use of copyright and the creation of a copyright shell.  “Promote” details how a Micro Social Network, or MSN, is used to promote segments of the patent pending idea to attract research, knowledge and funding partners as members of the MSN. Once formed, the MSN is then used to “Produce” the product through crowdfunding and Viratech’s innovative approach to compensating members for their micro social network activity and collaboration.

Newswire’s role in the new collaboration agreement is in the area of Promotion.  The collaborative agreement provides any micro social network owner access to unlimited free press release distribution via Newswire. This allows the individual or small business owner of the MSN to promote their idea, entice funding and development partners through at unique engagement funnel, and ultimately deliver their innovative advancement in diagnostics or therapies to those that can benefit from it sooner rather than later.

“Viratech believes that its open source biotech research social network platform will change the landscape of intellectual property protection and allow medicine to finally become open sourced,” said Dr. Kevin Buckman, CEO.  “By giving small companies enhanced intellectual property protection to recruit development partners, Viratech has streamlined the process of taking an idea and making it a reality. With the emphasis of such technologies on saving lives and improving quality of life first, and consideration of revenue or profit second, this business model is a direct counter to the current large pharmaceutical company approach of stifling innovation for protection of profits.” he added.

“Newswire considers it an honor and a privilege to be the promotion outlet for such an engine that allows the development partners of Viratech Corp access to free unlimited press release distribution,” said Doug Brown, president of Newsire.

About Viratech Corp.

Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform, Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open sourced.  This is accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.

Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro social network as a utility to promote and crowdfund the research and development to produce the new technology.

About Newswire

Newswire, is a social network news agency of independent journalists.  Newswire’s intellectual property leverages social networking with collective search engine optimization to give journalists the tools, credibility, and distribution they need to report the news via a single unified voice.

Newswire’s unique value proposition lies in our Journalist Social Network.  Independent writers, bloggers, photographers, and videographers represent one of the most powerful and overlooked search engine optimization forces on the Internet.  Newswire’s platform gives them an editorial process, ethics policy, and the technology they need to harness their collective power and distribute news via search engine placement.

In addition, Newswire offers businesses unique access to our journalist network and technology allowing them to broadcast their message to thousands of news outlets worldwide.  Newswire’s press release distribution services cater to both small/medium sized businesses and large publicly traded companies.  Newswire’s distribution engine places client news on up to 50,000 sites throughout the web, gets news to National Media Outlets, and targets industry specific trade publications.

Forward-Looking Statements:

This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.

 

Contact: Kevin Buckman MD

Viratech, Corp.

http://viratech.org

Email Contact: info@viratech.org